newsfilter
← Latest News
Business Wire·

Infinity Pharmaceuticals to Participate in Upcoming H.C. Wainwright Global Investment Conference

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced that management will be presenting a corporate over